Clinical Trial Update: Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and pharmacokinetics of tirabrutinib (GS-4059) in healthy volunteers and rheumatoid arthritis patients completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tirabrutinib (tirabrutinib)

Snippet

Sponsor: Gilead Sciences | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2020-09-09